Low susceptibility of NC/Nga mice to the lipopolysaccharide-mediated lethality with d-galactosamine sensitization and the involvement of fewer natural killer T cells
暂无分享,去创建一个
N. Koide | Tomoaki Yoshida | T. Yokochi | A. Morikawa | B. Badamtseren | E. Odkhuu | A. Haque | Y. Naiki | T. Komatsu | T. Yoshida | Battuvshin Badamtseren
[1] K. Kabashima,et al. Sustained Exogenous Expression of Therapeutic Levels of IFN-γ Ameliorates Atopic Dermatitis in NC/Nga Mice via Th1 Polarization , 2010, The Journal of Immunology.
[2] S. Tanabe,et al. Oral administration of a galactooligosaccharide preparation inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice. , 2010, International Journal of Molecular Medicine.
[3] N. Koide,et al. Low susceptibility of NC/Nga mice to tumor necrosis factor-alpha-mediated lethality and hepatocellular damage with D-galactosamine sensitization. , 2009, Clinical immunology.
[4] F. Hassan,et al. The mechanism of development of acute lung injury in lethal endotoxic shock using α‐galactosylceramide sensitization , 2008, Clinical and experimental immunology.
[5] F. Hassan,et al. Lipopolysaccharide enhances interferon-γ-induced nitric oxide (NO) production in murine vascular endothelial cells via augmentation of interferon regulatory factor-1 activation , 2007, Journal of endotoxin research.
[6] K. H. Kim,et al. Suppression of spontaneous dermatitis in NC/Nga murine model by PG102 isolated from Actinidia arguta. , 2007, The Journal of investigative dermatology.
[7] N. Shinomiya,et al. Mice deficient in Vβ8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction , 2007, Clinical and Experimental Medicine.
[8] F. Hassan,et al. Lethal endotoxic shock using α-galactosylceramide sensitization as a new experimental model of septic shock , 2006, Laboratory Investigation.
[9] F. Hassan,et al. Augmentation of lipopolysaccharide-induced nitric oxide production by α-galactosylceramide in mouse peritoneal cells , 2005, Journal of endotoxin research.
[10] S. Seki,et al. A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine , 2005, Virchows Archiv.
[11] 寺田 信. Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice , 2005 .
[12] T. Shiohara,et al. Animal models for atopic dermatitis: are they relevant to human disease? , 2004, Journal of dermatological science.
[13] K. Nishioka,et al. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: possible shift from a Th2- to Th1-predominance. , 2004, Journal of dermatological science.
[14] Hiroyuki Tanaka,et al. Establishment of allergic dermatitis in NC/Nga mice as a model for severe atopic dermatitis. , 2004, Biological & pharmaceutical bulletin.
[15] K Mihara,et al. Vital role of the itch–scratch response in development of spontaneous dermatitis in NC/Nga mice , 2004, The British journal of dermatology.
[16] R. Silverstein. Review: D-Galactosamine lethality model: scope and limitations , 2004 .
[17] R. Silverstein. D-galactosamine lethality model: scope and limitations. , 2004, Journal of endotoxin research.
[18] S. Fan,et al. STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[19] H. Matsuda,et al. Inability of IL-12 to Down-Regulate IgE Synthesis Due to Defective Production of IFN-γ in Atopic NC/Nga Mice1 , 2001, The Journal of Immunology.
[20] M. Smyth,et al. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. , 2001, International immunology.
[21] T. Majima,et al. The Mechanism of a Defective IFN-γ Response to Bacterial Toxins in an Atopic Dermatitis Model, NC/Nga Mice, and the Therapeutic Effect of IFN-γ, IL-12, or IL-18 on Dermatitis1 , 2001, The Journal of Immunology.
[22] G. Tiegs,et al. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. , 2001, The Journal of clinical investigation.
[23] L. Moldawer,et al. Reduced Susceptibility of Nonobese Diabetic Mice to TNF-α and d-Galactosamine-Mediated Hepatocellular Apoptosis and Lethality1 , 2000, The Journal of Immunology.
[24] N. Koide,et al. Augmentation of Nitric Oxide Production by Gamma Interferon in a Mouse Vascular Endothelial Cell Line and Its Modulation by Tumor Necrosis Factor Alpha and Lipopolysaccharide , 2000, Infection and Immunity.
[25] N. Koide,et al. Expression of Fas and Fas Ligand on Mouse Renal Tubular Epithelial Cells in the Generalized Shwartzman Reaction and Its Relationship to Apoptosis , 1999, Infection and Immunity.
[26] N. Koide,et al. Role of Nitric Oxide in Lipopolysaccharide-Induced Hepatic Injury in d-Galactosamine-Sensitized Mice as an Experimental Endotoxic Shock Model , 1999, Infection and Immunity.
[27] H. Sato,et al. IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. , 1999, Journal of immunology.
[28] N. Koide,et al. Apoptotic cell death in the response of D-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model , 1996, Infection and immunity.
[29] G. Trinchieri,et al. Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction , 1994, The Journal of experimental medicine.
[30] M. Leist,et al. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. , 1994, Journal of immunology.
[31] B. Ryffel,et al. Interferon gamma receptor deficient mice are resistant to endotoxic shock , 1994, The Journal of experimental medicine.
[32] A. Billiau,et al. Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice , 1990, The Journal of experimental medicine.
[33] S. Tannenbaum,et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.